NEUMORA THERAPEUTICS INC (NMRA) Institutional Shareholders
NEUMORA THERAPEUTICS INC (NMRA) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $127.75M in NMRA holdings during the latest filing period.
Siren, L.L.C. is currently the largest disclosed institutional shareholder of NMRA tracked by InsiderSet, reporting ownership valued at approximately $14.45M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $6.20M, representing an estimated loss of -57.06% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 61% of the total disclosed NMRA value among the investors covered in this analysis. Major shareholders include Siren, L.L.C., Blackrock, Inc., Softbank Group Corp., and several other long-term asset managers with concentrated positions in NEUMORA THERAPEUTICS INC (NMRA).
This page ranks the largest institutional NMRA shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
110
Total Reported Value
$127.75M
Largest Holder
Siren, L.L.C.
Largest Position
$14.45M
Insider Transactions (90d)
21
Latest Filing Quarter
Q2 2026
New Institutional Positions
150
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Siren, L.L.C. | 0.29% | 8,497,822 | $14,446,297 | $6,203,410 | -$8,242,887 | -57.06% | |
| Blackrock, Inc. | 0.00% | 7,791,869 | $13,246,178 | $5,688,064 | -$7,558,114 | -57.06% | |
| Softbank Group Corp. | 0.06% | 6,090,301 | $10,353,512 | $4,445,920 | -$5,907,592 | -57.06% | |
| Vanguard Capital Management Llc | 0.00% | 4,669,585 | $7,938,295 | $3,408,797 | -$4,529,498 | -57.06% | |
| Mic Capital Management Uk Llp | 1.92% | 4,460,700 | $7,583,190 | $3,256,311 | -$4,326,879 | -57.06% | |
| Fmr Llc | 0.00% | 3,498,869 | $5,948,077 | $2,554,174 | -$3,393,903 | -57.06% | |
| Wellcome Trust Ltd (The) As Trustee Of The Wellcome Trust | 0.06% | 3,309,123 | $5,625,509 | $2,415,660 | -$3,209,849 | -57.06% | |
| Geode Capital Management, Llc | 0.00% | 2,607,289 | $4,433,341 | $1,903,321 | -$2,530,020 | -57.07% | |
| Iconiq Capital, Llc | 0.13% | 2,559,090 | $4,350,453 | $1,868,136 | -$2,482,317 | -57.06% | |
| Two Sigma Investments, Lp | 0.00% | 2,244,829 | $3,816,209 | $1,638,725 | -$2,177,484 | -57.06% | |
| Orbimed Advisors Llc | 0.07% | 2,139,882 | $3,637,799 | $1,562,114 | -$2,075,685 | -57.06% | |
| Lunate Capital Ltd | 1.84% | 2,124,143 | $3,611,043 | $1,550,624 | -$2,060,419 | -57.06% | |
| Boxer Capital Management, Llc | 0.26% | 2,000,000 | $3,400,000 | $1,460,000 | -$1,940,000 | -57.06% | |
| Johnson & Johnson | 0.39% | 1,849,445 | $3,144,057 | $1,350,095 | -$1,793,962 | -57.06% | |
| State Street Corp | 0.00% | 1,582,119 | $2,689,602 | $1,154,947 | -$1,534,655 | -57.06% | |
| Tudor Investment Corp Et Al | 0.01% | 1,356,147 | $2,305,450 | $989,987 | -$1,315,463 | -57.06% | |
| Ikarian Capital, Llc | 0.36% | 1,278,408 | $2,173,294 | $933,238 | -$1,240,056 | -57.06% | |
| Renaissance Technologies LLC | Jim Simons | 0.00% | 1,262,304 | $2,145,917 | $921,482 | -$1,224,435 | -57.06% |
| Affinity Asset Advisors, Llc | 0.09% | 1,070,651 | $1,820,107 | $781,575 | -$1,038,532 | -57.06% | |
| Marshall Wace, Llp | 0.00% | 904,458 | $1,537,579 | $660,254 | -$877,325 | -57.06% | |
| Vanguard Portfolio Management Llc | 0.00% | 894,791 | $1,521,145 | $653,197 | -$867,948 | -57.06% | |
| Citadel Advisors Llc | 0.00% | 828,933 | $1,409,187 | $605,121 | -$804,066 | -57.06% | |
| Charles Schwab Investment Management Inc | 0.00% | 823,583 | $1,400,091 | $601,216 | -$798,875 | -57.06% | |
| Northern Trust Corp | 0.00% | 800,571 | $1,360,971 | $584,417 | -$776,554 | -57.06% | |
| Vanguard Fiduciary Trust Co | 0.00% | 706,667 | $1,201,334 | $515,867 | -$685,467 | -57.06% | |
| Alphacore Capital Llc | 0.02% | 638,784 | $1,085,933 | $466,312 | -$619,621 | -57.06% | |
| Dimensional Fund Advisors Lp | 0.00% | 577,615 | $982,109 | $421,659 | -$560,450 | -57.07% | |
| Acadian Asset Management Llc | 0.00% | 536,186 | $907,000 | $391,416 | -$515,584 | -56.85% | |
| Millennium Management Llc | 0.00% | 509,210 | $865,657 | $371,723 | -$493,934 | -57.06% | |
| Jacobs Levy Equity Management, Inc | 0.00% | 405,324 | $689,051 | $295,887 | -$393,164 | -57.06% | |
| Susquehanna International Group, Llp | 0.00% | 374,014 | $635,824 | $273,030 | -$362,794 | -57.06% | |
| Squarepoint Ops Llc | 0.00% | 363,145 | $617,347 | $265,096 | -$352,251 | -57.06% | |
| Boothbay Fund Management, Llc | 0.01% | 335,267 | $569,954 | $244,745 | -$325,209 | -57.06% | |
| Morgan Stanley | 0.00% | 319,421 | $543,017 | $233,177 | -$309,840 | -57.06% | |
| Caption Management, Llc | 0.02% | 313,217 | $532,469 | $228,648 | -$303,821 | -57.06% | |
| Goldman Sachs Group Inc | 0.00% | 303,862 | $516,566 | $221,819 | -$294,747 | -57.06% | |
| Bank Of New York Mellon Corp | 0.00% | 247,545 | $420,827 | $180,708 | -$240,119 | -57.06% | |
| Invesco Ltd. | 0.00% | 243,195 | $413,432 | $177,532 | -$235,900 | -57.06% | |
| Gsa Capital Partners Llp | 0.03% | 241,110 | $410,000 | $176,010 | -$233,990 | -57.07% | |
| Cerity Partners Llc | 0.00% | 239,653 | $407,411 | $174,947 | -$232,464 | -57.06% | |
| Susquehanna Portfolio Strategies, Llc | 0.01% | 237,747 | $404,170 | $173,555 | -$230,615 | -57.06% | |
| Velan Capital Investment Management Lp | 0.24% | 230,000 | $391,000 | $167,900 | -$223,100 | -57.06% | |
| Jane Street Group, Llc | 0.00% | 229,930 | $390,881 | $167,849 | -$223,032 | -57.06% | |
| Bridgeway Capital Management, Llc | 0.01% | 225,000 | $382,500 | $164,250 | -$218,250 | -57.06% | |
| Adar1 Capital Management, Llc | 0.02% | 210,000 | $357,000 | $153,300 | -$203,700 | -57.06% | |
| Simplex Trading, Llc | 0.01% | 199,810 | $339,677 | $145,861 | -$193,816 | -57.06% | |
| Canada Pension Plan Investment Board | 0.00% | 198,400 | $337,280 | $144,832 | -$192,448 | -57.06% | |
| Addis & Hill, Inc | 0.15% | 163,386 | $277,757 | $119,272 | -$158,485 | -57.06% | |
| Maniro Ltd | 0.06% | 158,231 | $268,992 | $115,509 | -$153,483 | -57.06% | |
| Ubs Group Ag | 0.00% | 143,725 | $244,332 | $104,919 | -$139,413 | -57.06% |
Frequently asked questions about NMRA
Who owns the most NMRA stock?
The largest holders of NMRA are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for NEUMORA THERAPEUTICS INC (NMRA).
Is NMRA widely held by superinvestors?
Many widely followed stocks like NMRA appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly NMRA is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.